Cleveland Biolabs Inc (NASDAQ:CBLI)

2.74
Delayed Data
As of Apr 25
 -0.06 / -2.14%
Today’s Change
2.24
Today|||52-Week Range
4.36
-31.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$38.9M

Company Description

Cleveland BioLabs, Inc. is a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

Contact Information

Cleveland BioLabs, Inc.
73 High Street
Buffalo New York 14203
P:(716) 849-6810
Investor Relations:

Employees

Shareholders

Other institutional2.12%
Mutual fund holders1.79%
Individual stakeholders1.16%

Top Executives

Yakov KoganCEO, Principal Financial Officer & Secretary
Langdon L. MillerPresident & Chief Medical Officer
Andrei V. GudkovChief Scientific Officer
Ann Lenich HardsExecutive Vice President-Regulatory Affairs